|
|
|
|
|
|
|
|
|
|
|
Programming a Seamless Supply Chain
|
|
|
| By
Michelle Hoffman
|
|
|
|
Information technology is the glue that should unify a company while ironically, it enables further fragmentation. Experts talk about the successes and challenges for IT in helping a company function efficiently.
|
|
|
|
|
|
|
|
|
Mixed-Flow Fans Meet Biosafety Level Laboratory Requirements
|
|
|
| By
Charlie Gans
|
|
|
|
Mixed-flow impeller systems exhaust laboratory workstation fume hoods, prevent reentrainment into the facility and adjacent facilities, and help companies comply with appropriate pollution-control standards.
|
|
|
|
Evaluating Mucilage from Aloe Barbadensis Miller as a Pharmaceutical Excipient for Sustained-Release Matrix Tablets
|
|
|
| By
Girish K. Jani
,
Dhiren P. Shah
,
Vineet C. Jain
,
Manish J. Patel
,
Disha A. Vithalani
|
|
|
|
Natural gums and mucilage have been widely explored as pharmaceutical excipients. The goal of this study was to extract mucilage from the leaves of Aloe barbadensis Miller and to study its functionality as an excipient in pharmaceutical sustained-release tablet formulations.
|
|
|
|
Improving a Pharmaceutical Water System based on a Risk Analysis Approach
|
|
|
| By
Arturo Toledo Rivero
,
Nelson Sierra Prado
,
Anamarys González Alvarez
,
Danelys Cardoza Lobaina
|
|
|
|
In this study, fault tree analysis applied to a water pretreatment and purification installation exposed cause-and-effect complex interrelations in possible fault events.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Whom Can Patients Rely On?
|
|
|
| By
Angie Drakulich
|
|
|
|
As the mother of a 15-month-old, I was quite shaken last month to hear about over-the-counter cold medicines for children under age 2 being pulled off the shelves. Glued to the news, I wondered if the decongestant I had given my daughter when she was sick would have any negative impact on her long-term health.
|
|
|
|
|
|
|
|
|
In the Field
|
|
|
|
The US Food and Drug Administration launched a new program on Oct. 4 to increase the number and variety of generic drugs available to the public, beginning in fiscal year 2008. The Generic Initiative for Value and Efficiency (GIVE) will use existing resources to help the agency "modernize and streamline the generic drug approval process," according to FDA.
|
|
|
|
|
|
|
|
|
In the Spotlight
|
|
|
|
Editors' Picks of Pharmaceutical Science & Technology Innovations
|
|
|
|
|
|
|
|
|
|
